Overexpression of TrkC in human MTC cells exhibited an increased growth rate, tumorigenic capacity, and primary tumor formation in vivo relative to control cells before ligand addition and after NT-3 addition, consistent with the fact that TrkC is phosphorylated before ligand addition [32]. The gene discussed is NTRK3; the disease is neoplasm.